Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 11-2021 | 08-2021 | 05-2021 | 02-2021 | 11-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 31 | 192 | 175 | 89 | 1 |
| Accounts receivable | 14 | 55 | 13 | -4 | -42 |
| Other Working Capital | -52 | 490 | 462 | -462 | -1,195 |
| Other Operating Activity | -1,275 | -1,439 | -1,565 | -2,338 | -474 |
| Operating Cash Flow | $-1,282 | $-703 | $-915 | $-2,715 | $-1,711 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -41 | -55 | 0 | -1 | 4 |
| Net Acquisitions | -57 | 34 | 0 | 406 | N/A |
| Purchase Of Investment | 0 | 0 | 0 | -406 | -50 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 100 |
| Other Investing Activity | 21 | 0 | 0 | 0 | 1,106 |
| Investing Cash Flow | $-77 | $-21 | $0 | $-1 | $1,161 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 0 | 0 | 3,083 | 1,496 |
| Other Financing Activity | 25 | 0 | 0 | 1,868 | 0 |
| Financing Cash Flow | $25 | $0 | $0 | $4,951 | $1,496 |
| Beginning Cash Position | 3,383 | 4,107 | 5,022 | 2,787 | 1,841 |
| End Cash Position | 2,049 | 3,383 | 4,107 | 5,022 | 2,787 |
| Net Cash Flow | $-1,334 | $-724 | $-915 | $2,235 | $946 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,282 | -703 | -915 | -2,715 | -1,711 |
| Capital Expenditure | -41 | -55 | N/A | -1 | N/A |
| Free Cash Flow | -1,323 | -758 | -915 | -2,716 | -1,711 |